Image

Global Liposomal Drugs Market – Industry Trends and Forecast to 2029

Healthcare

Image

Global Liposomal Drugs Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Jul 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Liposomal Drugs Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 4.16 USD Billion
Diagram Market Size (Forecast Year) USD 7.99 USD Billion
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Liposomal Drugs Market, By Type (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphoteracin B, Others), Application (Fungal Infection Therapy, Cancer and Tumor Therapy, Ocular and Pulmonary), Industry (Pharmaceutical, Cosmetic, Food, Farming) – Industry Trends and Forecast to 2029

Liposomal Drugs Market

Liposomal Drugs Market Analysis and Size

The global liposomal drugs market is expected to witness significant growth during the forecast period. Liposomes help in delivering drugs by the process of diffusion rather than by direct cell fusion. They enable a diverse range of drugs that is encapsulated by these vesicles, which contributes to the growth of the global market. The increasing incidence of fungal disorders is prompting a lot in increasing the demand for liposomal formulations of Amphotericin B. Thus, it helps in leading the market growth.

Data Bridge Market Research analyses a growth rate in the global liposomal drugs market in the forecast period 2022-2029. The expected CAGR of global liposomal drugs market is tend to be around 8.50% in the mentioned forecast period. The market was valued at USD 4.16 billion in 2021, and it would grow upto USD 7.99 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Liposome can be defined as a spherical-shaped vesicle that involves one or more phospholipid bilayers, similar to the structure of cell membranes. The liposome focusses on a particular part or tissue instead of whole body part. Liposome operates as a tool and reproduction in many scientific fields. This is further anticipated to impede the growth of the liposomal drugs market in the timeline period.

Liposomal Drugs Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Type (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphoteracin B, Others), Application (Fungal Infection Therapy, Cancer and Tumor Therapy, Ocular and Pulmonary), Industry (Pharmaceutical, Cosmetic, Food, Farming)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Johnson & Johnson Services, Inc. (U.S.), Gilead Sciences, Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Serum Institute of India Pvt. Ltd. (India), Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd (China), Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd (Israel), Janssen Global Services, LLC (Belgium), CELSION corporation (U.S.), Abbott (U.S.), Ipsen Pharma (France), Spectrum Pharmaceuticals, Inc. (U.S.), Takeda Pharmaceutical Company Limited. (Japan), Merrimack (U.S.), Evonik Industries AG (Germany)

Market Opportunities

  • Enhancing Circulation Time of Hydrophobic Substances
  • Advanced Clinical Research and Technological Advancement

Global Liposomal Drugs Market Dynamics

Drivers

  • Greater Adoption of Quality by Design (QbD) Over Traditional Processes

Processes have been streamlined as a result of the adoption of rational-based approaches such as QbD over empirical and simulation-based approaches. In comparison to conventional methodologies focused on trial and error, QbD is based on a fact-based rational approach and aids in more robust decision-making. The popularity and implementation of the QbD technique are anticipated to rise.

  • Increasing Use of Liposomal contrast imaging agents

Liposomes are conditioned for therapeutic, diagnostic, and image-guided drug delivery. Paramagnetic liposomes are widely used in molecular and cell imaging and image-guided drug delivery. 

 Drug-loaded paramagnetic liposomes have been used for therapeutic interventions. Liposomes have long been provided as a medium for delivering paramagnetic ions. Increasing imaging modalities such as MRI, CT scans and SPECT imaging are expected to complement the growth of the global liposome market.

Opportunities

  • Enhancing Circulation Time of Hydrophobic Substances

Galbanic acid (Gba) in improved liposomal formulations is being used in the liposome drug delivery market to maximise the therapeutic efficacy of PEGylated liposomal Doxorubicin. A sesquiterpene coumarin with powerful antiangiogenic properties, galvanic acid has a promising future as an anti-cancer drug. Galbanic acid's water solubility restrictions limit its potential for use in medicine. To get around the drawbacks of poor Gba solubility, businesses in the liposome drug delivery market are expanding the application of PEGylated liposomal Gba made using the thin film hydration plus extrusion approach.

  • Advanced Clinical Research and Technological Advancement

For pharmaceutical businesses, new methods for liposome surface modification are creating more opportunities. As a valuable biocompatible instrument for the vehiculation and administration of lipophilic, hydrophilic, and ampiphilic chemicals, liposome drug delivery is receiving a lot of attention. However, some of the challenges faced by businesses in the liposome drug delivery market include significant toxicity and resistance in large dosages. As a result, businesses are converting from basic conventional vesicles to second-generation liposomes by adjusting the surface and lipid composition with various ligands.

Restraints/Challenges

  • High Cost

The huge expenditure required for developing the liposomal drugs surely hamper the market growth.

This global liposomal drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global liposomal drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Liposomal Drugs Market Scope

The global liposomal drugs market is segmented on the basis of type, application, industry. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Liposomal Doxorubicin
  • Liposomal Paclitaxel
  • Liposomal Amphoteracin B
  • Others

Application

  • Fungal Infection Therapy
  • Cancer and Tumor Therapy
  • Ocular and Pulmonary

Industry

  • Pharmaceutical
  • Cosmetic
  • Food
  • Farming

Liposomal Drugs Market Regional Analysis/Insights

The global liposomal drugs market is analysed and market size insights and trends are provided by type, application, industry as referenced above.

The major countries covered in the global liposomal drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the liposomal drugs market due to the occurrence of major key players. Furthermore, the rise in the incidences of cancer will further boost the growth of the liposomal drugs market in the region during the forecast period. Asia-Pacific is projected to observe significant growth in the liposomal drugs market due to the rise in the number of patients suffering from chronic diseases. Moreover, the players' attention on bolstering the existence in the advancing countries is further anticipated to propel the growth of the liposomal drugs market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Liposomal Drugs Market Share Analysis

The global liposomal drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global liposomal drugs market

Key players operating in the global liposomal drugs market include:

  • Johnson & Johnson Services, Inc. (U.S.)
  • Gilead Sciences, Inc. (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Serum Institute of India Pvt. Ltd. (India)
  • Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd (China)
  • Novartis AG (Switzerland)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Janssen Pharmaceuticals, Inc. (Belgium)
  • CELSION corporation (U.S.)
  • Abbott (U.S.)
  • Ipsen Pharma (France)
  • Spectrum Pharmaceuticals, Inc. (U.S.)
  • Takeda Pharmaceutical Company Limited. (Japan)
  • Merrimack Pharmaceuticals (U.S.)
  • Evonik Industries AG (Germany)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

Global Liposomal Drugs Market segmented By Application such as Fungal Infection Therapy, Cancer and Tumor Therapy, Ocular and Pulmonary.
The major players covered in the liposomal drugs market report are Johnson & Johnson Services, Inc., Gilead Sciences, Inc., Luye Boston R&D IIC, Sun Pharmaceutical Industries Ltd., Pacira BioSciences, Inc., Serum Institute of India Pvt. Ltd., Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd, Novartis AG, Teva Pharmaceutical Industries Ltd, Janssen Pharmaceuticals, Inc., CELSION, Inc., Abbott, Ipsen Pharma, Spectrum Pharmaceuticals, Inc., Astellas Pharma Inc., Takeda Pharmaceutical Company Limited., Merrimack Pharmaceuticals, T&T Scientific Corp., Sigma-Tau Group Industrie Farmaceutiche Riunite S.p.A., Evonik Industries AG, among other domestic and global players.
This liposomal drugs market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market.
Asia Pacific is projected to observe significant amount of growth in the liposomal drugs market due to the rise in the number of patients that are suffering from chronic diseases.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials